Inclusion Criteria:

• Premenopausal and postmenopausal women between the ages of 18 to 70 years.
• Ability to give informed consent.
• Breast cancer survivors who have undergone surgery, including lumpectomy and simple or total mastectomy, followed by chemotherapy or a combination of chemo- and radio-therapy. We have elected to study survivors instead of patients actively undergoing treatment to alleviate subject burden and risk during this protocol.
• Stage I to III breast cancer survivors.
• Breast cancer survivors who have finished their chemotherapy and/or radiotherapy at least one month prior to 60 months prior.
• Breast cancer survivors with above-normative levels of fatigue.

Exclusion Criteria:

• Breast cancer patients who are currently receiving or who are scheduled to receive radiation or chemotherapy during the course of this intervention study.
• Patients with current major depression, current or history of prior bipolar illness, currently on psychotropic medications.
• Patients with other diseases that are known to induce fatigue (e.g., thyroid disorder; sleep disorders).
• Patients with other inflammatory diseases that affect cytokine levels.
• Patients with a history of other cancers, and stage IV breast cancer.
• Patients undergoing current chemotherapy and/or radiotherapy.
• Men with breast cancer.
• Substance abuse/dependence.
• Continued use of another biofield-based intervention (e.g., Reiki, Qi-Gong, Healing Touch, Therapeutic Touch, Johrei).